Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan.
この論文をさがす
抄録
Liver transplantation for patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) remains challenging. The advent of highly active antiretroviral therapy (HAART) for HIV has reduced mortality from opportunistic infection related to acquired immunodeficiency syndrome dramatically, while about 50% of patients die of end-stage liver cirrhosis resulting from HCV. In Japan, liver cirrhosis frequently develops after HCV-HIV coinfection resulting from previously transfused infected blood products for hemophilia. The problems of liver transplantation for those patients arise from the need to control calcineurin inhibitor with HAART drugs, the difficulty of using interferon after liver transplantation with HAART, and the need to control intraoperative coagulopathy associated with hemophilia. We review published reports of liver transplantation for these patients in the updated world literature.
Surgery Today, 41(10), pp.1325-1331; 2011
収録刊行物
-
- Surgery Today
-
Surgery Today 41 (10), 1325-1331, 2011-10
Springer Verlag
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1050850247228246784
-
- NII論文ID
- 10030228509
-
- NII書誌ID
- AA10824685
-
- ISSN
- 09411291
- 14362813
-
- HANDLE
- 10069/26865
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- CiNii Articles